FDA Preventive Maintenance-Repair Agreement for Revvity Spectrum IVIS system

The FDA Office of Acquisition and Grant Services seeks a preventive maintenance and repair agreement for a Revvity Spectrum In Vivo Imaging system (IVIS, Model IVISSPECTRUM, S/N IS2117N8165) at its White Oak Animal Program facility in Silver Spring, Maryland, with responses due July 31, 2026 at 2:00 p.m. CDT. This is a total small business set-aside under NAICS 811210 with a $34 million size standard.

The base performance period runs August 15, 2026 through August 14, 2027, with three optional one-year renewal periods. Services include annual preventive maintenance (labor, travel, parts) covering CCD camera and optical system calibration, system verification, and cleaning; on-site corrective visits as required; unlimited technical and remote support Monday through Friday, 8:30 a.m. to 5:00 p.m. local time; software and firmware updates; and annual training for 15 researchers on system operation, imaging techniques, troubleshooting, and data analysis. Contractor must submit detailed field service reports within five business days of each visit.

The contract is firm-fixed-price with pricing inclusive of all labor, travel, replacement parts, and components. Non-OEM offerors must demonstrate experience servicing the same equipment, provide qualifications of field service engineers, establish supply chain relationships with the OEM, and supply verifiable client references. Offerors must register in SAM.gov, provide their UEI number, submit an Accessibility Conformance Report for invoices and service records, certify compliance under FAR 52.222-48 regarding Service Contract Act exemption, and provide country-of-origin information for Buy American Act compliance. Payment terms are net 30 days after government acceptance. Tim Walbert (timothy.walbert@fda.hhs.gov) is the Contracting Officer.